Your browser doesn't support javascript.
loading
Randomized, controlled, participant- and rater-blind trial of pharmacogenomic test-guided treatment versus treatment as usual for major depressive disorder.
Perlis, Roy H; Dowd, Daniel; Fava, Maurizio; Lencz, Todd; Krause, David S.
Afiliación
  • Perlis RH; Department of Psychiatry and Division of Clinical Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Dowd D; Clinical Research & Development and Medical Affairs, Genomind, Inc., King of Prussia, Pennsylvania.
  • Fava M; Department of Psychiatry and Division of Clinical Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Lencz T; Department of Psychiatry, Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.
  • Krause DS; Clinical Research & Development and Medical Affairs, Genomind, Inc., King of Prussia, Pennsylvania.
Depress Anxiety ; 37(9): 834-841, 2020 09.
Article en En | MEDLINE | ID: mdl-32383277

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno Depresivo Mayor Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Depress Anxiety Asunto de la revista: PSIQUIATRIA Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno Depresivo Mayor Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Depress Anxiety Asunto de la revista: PSIQUIATRIA Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos